Serum collection and IBD biobank supported by the Bundesministerium für Bildung und Forschung (German Ministry of Education and Research), Kompetenznetz chronisch entzündliche Darmerkrankungen (Competence network "Inflammatory Bowel Disease").
AbstractChemerin is an adipose tissue-secreted protein that stimulates chemotaxis of cells of the innate immune system. Inflammatory bowel disease (IBD) is linked to an impaired immune response and, therefore, we hypothesized that systemic chemerin may be altered in IBDpatients. Serum was collected from patients with Crohn´s disease (CD, 230 patients), ulcerative colitis (UC, 80 patients) and healthy controls (HC, 80 probands). Chemerin and adiponectin, which has already been measured in the serum of similar cohorts by others, were determined by ELISA. Sytemic chemerin concentrations were significantly elevated in serum of CD and UC patients compared to HC, and were also found to be higher in the serum of males with CD compared to males with UC. Adiponectin levels were lower in CD compared to UC and HC with similar circulating concentrations. In serum of male but not female patients chemerin levels were higher in UC patients with active disease whereas adiponectin was reduced. In CD elevated chemerin was associated with remission in males only.Treatment with corticosteroids was linked to elevated adiponectin in male CD patients and higher chemerin in female UC patients. Unlike adiponectin that is elevated in female serum in all cohorts analysed, chemerin was only higher in the serum of female UC patients.These data indicate that the levels of circulating chemerin are elevated in patients suffering from UC and CD whereas adiponectin is reduced in the latter. Relations of the systemic 2 concentrations of these adipokines to disease activity and treatment are disease-and genderspecific.3